Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

被引：15

作者：

Ajonuma, Louis Chukwuemeka ^{[1
]}

机构：

[1] St Marys Matern Hosp, Etiti, Imo State, Nigeria

来源：

MEDICAL HYPOTHESES | 2008年 / 70卷 / 06期

关键词：

D O I：

10.1016/j.mehy.2007.11.004

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Ovarian hyperstimulation syndrome (OHSS) remains one of the most life-threatening and potentially fatal complications of assisted reproduction treatments (ART), due to excessive stimulation of the ovaries by exogenously administrated gonadotropins. The pathogenesis of OHSS remains obscure and patient treatments are empirical. However, vascular endothelial growth factor (VEGF) has been suggested to be responsible for OHSS. The present hypothesis aims to discuss the possible role of epithelial ion channels particularly cystic fibrosis transmembrane conductance regulator (CFTR) involvement in the pathogenesis of OHSS. This may provide grounds for the development of a better treatment strategy to reduce the risk of OHSS and improve in vitro fertilization (IVF) outcome. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1174 / 1178

页数：5

共 50 条

[1] Role of vascular endothelial cell growth factor (VEGF) and angiopoietins (ANGPTs) in ovarian hyperstimulation syndrome (OHSS)
de Zuniga, I.
Colaci, D.
Sobral, F.
Bisioli, C.
Scotti, L.
Abramovich, D.
Tesone, M.
Parborell, F.
HUMAN REPRODUCTION, 2011, 26 : I91 - I91
[2] Progesterone regulates ovarian vascular endothelial growth factor (VEGF) production in the ovarian hyperstimulation syndrome (OHSS)-model rats.
Ishikawa, K
Ohba, T
Okamura, Y
Tanaka, N
Matsuura, K
Okamura, H
BIOLOGY OF REPRODUCTION, 2000, 62 : 177 - 177
[3] Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model
Hortu, Ismet
Karadadas, Elif
Ozceltik, Gokay
Tavmergen, Erol
Tavmergen Goker, Ege Nazan
Yigitturk, Gurkan
Erbas, Oytun
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (04) : 1099 - 1108
[4] Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model
Ismet Hortu
Elif Karadadas
Gokay Ozceltik
Erol Tavmergen
Ege Nazan Tavmergen Goker
Gurkan Yigitturk
Oytun Erbas
Archives of Gynecology and Obstetrics, 2021, 303 : 1099 - 1108
[5] Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS)
Birinci, Hulya
Vatansever, Hafize Seda
Yuncu, Mehmet
REPRODUCTION FERTILITY AND DEVELOPMENT, 2021, 33 (16) : 799 - 809
[6] Vascular endothelial growth factor - mediator of OHSS? Editorial commentary
McDonough, PG
FERTILITY AND STERILITY, 2003, 79 (06) : 1466 - 1467
[7] Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome
Meldrum, DR
FERTILITY AND STERILITY, 2002, 78 (06) : 1170 - 1171
[8] Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome
Levin, ER
Rosen, GF
Cassidenti, DL
Yee, B
Meldrum, D
Wisot, A
Pedram, A
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11): : 1978 - 1985
[9] Partial Impairment of LH/hCG Receptor (LHR) Downregulation and Higher levels of Vascular Endothelial Growth Factor (VEGF) in Granulosa Cells as a Contributing Factor for Ovarian Hyperstimulation Syndrome (OHSS).
Zheng, Cuihong
Menon, Bindu
Gulappa, Thippeswamy
Menon, K. M. J.
REPRODUCTIVE SCIENCES, 2016, 23 : 80A - 80A
[10] Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report
Krasnow, JS
Berga, SL
Guzick, DS
Zeleznik, AJ
Yeo, KT
FERTILITY AND STERILITY, 1996, 65 (03) : 552 - 555

← 1 2 3 4 5 →